Updates and Advancements in Cellular Therapy at Roswell Park
Originally Broadcast: Thursday, November 9, 2023 6:00 - 7:30 PM EST - This program is intended for Hematologists, Oncologists, Pharmacists, Pathologists, and other healthcare professionals that care for cancer patients.
Clinical Scorecard: Updates and Advancements in Cellular Therapy at Roswell Park
At a Glance
Category Detail
Condition Cancer Key Mechanisms Cellular therapy, including CAR T-cell therapy and gene therapy. Target Population Cancer patients, specifically those with B cell malignancies, multiple myeloma, and solid tumors. Care Setting Oncology and hematology clinics, including specialized transplantation and cellular therapy services.
Key Highlights
Introduction of novel clinical trials targeting B cell malignancies and multiple myeloma in 2024. Expansion into solid tumor therapies, including ovarian cancer, by 2025. Focus on interdisciplinary collaboration to enhance patient care in cellular therapy. Guideline-Based Recommendations
Diagnosis
Identify appropriate candidates for cellular therapy based on cancer type and patient health. Management
Implement novel therapies and clinical trials for graft versus host disease prevention and relapse prevention. Monitoring & Follow-up
Conduct routine follow-up for immunizations and cancer screening post-transplant. Risks
Consider potential complications such as graft versus host disease and the need for donor selection. Patient & Prescribing Data
Patients with various cancers, including pediatric and adult populations.
Utilization of both standard care products and investigational therapies tailored to individual patient needs.
Clinical Best Practices
Ensure comprehensive patient management and follow-up in cellular therapy. Foster collaboration among multidisciplinary teams to optimize treatment outcomes. References
